Deadline for application
What we need
-A high level of motivation and interest.
-Degree in Biomedical Sciences or similar.
-Ability to handle varying workloads and aptitude for teamwork.
-High level of collaborative and communicative skills.
-Good level of English speaking and writing skills (required). Spanish (helpful).
-Study and characterize retinas from PIK3CA mutants.
-Perform studies with PIK3CA mutant cells in vitro.
-Perform preclinical testing using PIK3CA mutant cells.
-Genotype the mouse colony.
-Isolate primary endothelial cells.
What we offer
-An exciting and innovative research project.
-Working in the mixed basic and clinical research environment of the Josep Carreras Leukaemia Research Institute.
-Incorporation in a multinational and highly collaborative team.
-The stimulating environment of the Barcelona metropolitan area.
The Josep Carreras Leukaemia Research Institute (IJC) is a non-profit research institute based in Barcelona and dedicated to advancing our understanding about leukaemia and related disorders, in partnership with the University of Barcelona and University Autònoma of Barcelona. The IJC has laboratories in three clinical campuses: i) Clinic Hospital, ii) Sant Pau Hospital and iii) Germans Trias i Pujol Hospital. IJC serves as a collaborative hub for basic investigators and physicians to work together on fundamental biological and clinical aspects of leukaemia. The IJC offers an excellent work environment built around a multi-disciplinary fusion of ideas and state-of-the-art facilities.
Our research is devoted to study the biology of the endothelium and its role in disease towards the development of therapeutic strategies to target this compartment. Specifically, we aim to untacked the fundamental insights of vessel growth and function in developmental setting as well as to identify the pathological contexts in which the vasculature plays a critical role either intrinsically, as in vascular anomalies, or extrinsically as in cancer.
Please also visit our unit webpage:
Who we are?
Our mission is to carry out research into the basic, epidemiological, preventive, clinical and translational aspects of leukaemia and other hematologic malignancies.
The vision of the Josep Carreras Leukaemia Research Institute is that research will identify new therapeutic targets and enable us to develop more precise and less aggressive treatments. We aspire to understand the origin and development of leukaemia and other malignant haematological pathologies in order to be able to prevent them. We will work for a future in which all leukaemias will be curable.
The European Commission awarded the IJC the HR Excellence seal in July 2019. The IJC continues to work to maintain its policies in line with the Charter and Code principles.
The HRS4R has the main objective of ensuring that research centers of excellence implement and respect the requirements of the European Charter for Researchers and the Code of Conduct for hiring researchers (from here on referred to as the Charter and Code) within their human resources policies.
This EC initiative aims to promote training, professional development, and mobility for all European scientists. The IJC supports these values and principles, which will not only serve to strengthen its internal policies but will actively stimulate excellent research and firmly situate the organization as an institution with a stimulating working environment that favors the development of its scientists.
IJC is an equal opportunity employer. We evaluate qualified applicants without regard to race, color, religion, sex, national origin, disability, and other legally protected characteristics.
Place of presentation of the candidacies
How to apply
To apply for this opportunity, please send your resume and a cover letter (incl. the contact details of two referees) to firstname.lastname@example.org in the subject of the message: REF.: LT_MG_88.
Deadline for Applications
Please submit your application by Oct 10th, 2021.